Cargando…
Biologic Treatment in Combination with Lifestyle Intervention in Moderate to Severe Plaque Psoriasis and Concomitant Metabolic Syndrome: Rationale and Methodology of the METABOLyx Randomized Controlled Clinical Trial
Inflammatory diseases including psoriasis are associated with metabolic and cardiovascular comorbidities, including obesity and metabolic syndrome. Obesity is associated with greater psoriasis disease severity and reduced response to treatment. Therefore, targeting metabolic comorbidities could impr...
Autores principales: | Pinter, Andreas, Schwarz, Peter, Gerdes, Sascha, Simon, Jan C., Saalbach, Anja, Rush, James, Melzer, Nima, Kramps, Thomas, Häberle, Benjamin, Reinhardt, Maximilian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471656/ https://www.ncbi.nlm.nih.gov/pubmed/34578893 http://dx.doi.org/10.3390/nu13093015 |
Ejemplares similares
-
Effects of secukinumab on metabolic and liver parameters in plaque psoriasis patients
por: Gerdes, S., et al.
Publicado: (2019) -
ERAPSO: Revealing the High Burden of Obesity in German Psoriasis Patients
por: Schwarz, Peter E. H., et al.
Publicado: (2019) -
Hidradenitis Suppurativa and Concurrent Psoriasis: Comparison of Epidemiology, Comorbidity Profiles, and Risk Factors
por: Pinter, Andreas, et al.
Publicado: (2020) -
Concomitant Xeroderma pigmentosum and disseminated small plaque psoriasis: first case of an antinomic association
por: Ezzedine, Khaled, et al.
Publicado: (2008) -
The Societal Economic Impact of Secukinumab in First-Line Treatment of Moderate to Severe Plaque Psoriasis in Germany: An Open-Cohort Simulation
por: Seddik, Ahmed H., et al.
Publicado: (2021)